Annual Cash & Cash Equivalents
$8.73 M
-$13.34 M-60.45%
31 December 2023
Summary:
Predictive Oncology annual cash & cash equivalents is currently $8.73 million, with the most recent change of -$13.34 million (-60.45%) on 31 December 2023. During the last 3 years, it has risen by +$8.05 million (+1186.85%). POAI annual cash & cash equivalents is now -69.05% below its all-time high of $28.20 million, reached on 31 December 2021.POAI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$3.08 M
-$2.25 M-42.25%
30 September 2024
Summary:
Predictive Oncology quarterly cash and cash equivalents is currently $3.08 million, with the most recent change of -$2.25 million (-42.25%) on 30 September 2024. Over the past year, it has dropped by -$8.84 million (-74.16%). POAI quarterly cash and cash equivalents is now -93.14% below its all-time high of $44.88 million, reached on 30 June 2021.POAI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
POAI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.5% | -74.2% |
| 3 y3 years | +1186.8% | -92.6% |
| 5 y5 years | +5281.4% | +3022.7% |
POAI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -69.0% | +1186.8% | -92.6% | at low |
| 5 y | 5 years | -69.0% | +5688.3% | -93.1% | +3022.7% |
| alltime | all time | -69.0% | >+9999.0% | -93.1% | >+9999.0% |
Predictive Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.08 M(-42.3%) |
| June 2024 | - | $5.33 M(+2.6%) |
| Mar 2024 | - | $5.20 M(-40.5%) |
| Dec 2023 | $8.73 M(-60.5%) | $8.73 M(-26.7%) |
| Sept 2023 | - | $11.91 M(-19.3%) |
| June 2023 | - | $14.76 M(-20.6%) |
| Mar 2023 | - | $18.60 M(-15.7%) |
| Dec 2022 | $22.07 M(-21.7%) | $22.07 M(-13.1%) |
| Sept 2022 | - | $25.39 M(-10.1%) |
| June 2022 | - | $28.25 M(+12.5%) |
| Mar 2022 | - | $25.12 M(-10.9%) |
| Dec 2021 | $28.20 M(+4057.8%) | $28.20 M(-32.5%) |
| Sept 2021 | - | $41.77 M(-6.9%) |
| June 2021 | - | $44.88 M(+64.4%) |
| Mar 2021 | - | $27.30 M(+3924.7%) |
| Dec 2020 | $678.30 K(+349.8%) | $678.30 K(-72.6%) |
| Sept 2020 | - | $2.47 M(-27.1%) |
| June 2020 | - | $3.39 M(+11.1%) |
| Mar 2020 | - | $3.06 M(+1926.7%) |
| Dec 2019 | $150.80 K(-7.0%) | $150.80 K(+52.9%) |
| Sept 2019 | - | $98.60 K(+41.7%) |
| June 2019 | - | $69.60 K(-93.8%) |
| Mar 2019 | - | $1.12 M(+593.4%) |
| Dec 2018 | $162.20 K(-78.8%) | $162.20 K(-22.7%) |
| Sept 2018 | - | $209.90 K(-79.1%) |
| June 2018 | - | $1.00 M(-55.0%) |
| Mar 2018 | - | $2.23 M(+191.4%) |
| Dec 2017 | $766.20 K(-56.6%) | $766.20 K(+0.1%) |
| Sept 2017 | - | $765.70 K(-34.0%) |
| June 2017 | - | $1.16 M(-44.4%) |
| Mar 2017 | - | $2.09 M(+18.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $1.76 M(-63.7%) | $1.76 M(+178.0%) |
| Sept 2016 | - | $634.50 K(+8.8%) |
| June 2016 | - | $583.00 K(-62.0%) |
| Mar 2016 | - | $1.54 M(-68.4%) |
| Dec 2015 | $4.86 M(>+9900.0%) | $4.86 M(-37.2%) |
| Sept 2015 | - | $7.73 M(>+9900.0%) |
| June 2015 | - | $44.10 K(+1160.0%) |
| Mar 2015 | - | $3500.00(-78.7%) |
| Dec 2014 | $16.40 K(-83.9%) | $16.40 K(-93.3%) |
| Sept 2014 | - | $244.00 K(+507.0%) |
| June 2014 | - | $40.20 K(-69.2%) |
| Mar 2014 | - | $130.70 K(+28.1%) |
| Dec 2013 | $102.00 K(+678.6%) | $102.00 K(-68.9%) |
| Sept 2013 | - | $328.40 K(+139.5%) |
| June 2013 | - | $137.10 K(-63.2%) |
| Mar 2013 | - | $372.90 K(+2746.6%) |
| Dec 2012 | $13.10 K(-89.3%) | $13.10 K(-87.2%) |
| Sept 2012 | - | $102.10 K(+189.2%) |
| June 2012 | - | $35.30 K(+57.6%) |
| Mar 2012 | - | $22.40 K(-81.8%) |
| Dec 2011 | $123.00 K(+1208.5%) | $123.00 K(+58.3%) |
| Sept 2011 | - | $77.70 K(+34.9%) |
| June 2011 | - | $57.60 K(-82.6%) |
| Mar 2011 | - | $331.30 K(+3424.5%) |
| Dec 2010 | $9400.00(-43.4%) | $9400.00(-53.9%) |
| Sept 2010 | - | $20.40 K(+131.8%) |
| June 2010 | - | $8800.00(-78.3%) |
| Mar 2010 | - | $40.60 K(+144.6%) |
| Dec 2009 | $16.60 K(-96.4%) | $16.60 K(-75.7%) |
| Sept 2009 | - | $68.20 K(-85.3%) |
| Dec 2008 | $463.80 K | $463.80 K |
FAQ
- What is Predictive Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Predictive Oncology?
- What is Predictive Oncology annual cash & cash equivalents year-on-year change?
- What is Predictive Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Predictive Oncology?
- What is Predictive Oncology quarterly cash and cash equivalents year-on-year change?
What is Predictive Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of POAI is $8.73 M
What is the all time high annual cash & cash equivalents for Predictive Oncology?
Predictive Oncology all-time high annual cash & cash equivalents is $28.20 M
What is Predictive Oncology annual cash & cash equivalents year-on-year change?
Over the past year, POAI annual cash & cash equivalents has changed by -$13.34 M (-60.45%)
What is Predictive Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of POAI is $3.08 M
What is the all time high quarterly cash and cash equivalents for Predictive Oncology?
Predictive Oncology all-time high quarterly cash and cash equivalents is $44.88 M
What is Predictive Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, POAI quarterly cash and cash equivalents has changed by -$8.84 M (-74.16%)